SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Eli Lilly
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
647 21 0 LLY
Emcee:  Frank Stein Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
584Lilly, Amgen Ink Manufacturing Deal for Coronavirus Antibodies Eli Lilly & Moonray-9/19/2020
583COVID-19 treatment linked to B.C. biotech shows signs of reducing hospitalizatiMoonray-9/19/2020
582Eli Lilly Reports Success With COVID-19 Neutralizing Antibody Treatment GetMoonray-9/16/2020
581Lilly, Incyte Announce Initial Data From Adaptive COVID-19 Treatment Trial - QuMoonray-9/14/2020
580The world desperately needs coronavirus treatments, even if we get a vaccine. TMoonray-8/20/2020
579Eli Lilly Expands Pact With China Partner, Bringing Lymphoma Drug To U.S. o~~~ Moonray-8/18/2020
578U.S. begins trials of Eli Lilly’s antibody drug Berkeley Lovelace Jr The NatiMoonray28/5/2020
577More: Eli Lilly launches late-stage antibody treatment trial to be tested in USMoonray-8/3/2020
576Eli Lilly starts late-stage study of coronavirus drug in nursing homes PUBLISHGlenn Petersen28/3/2020
575LLY 153.00 -8.75 (-5.41%) As of 11:04AM EDT. Eli Lilly's stock rallies aMoonray-7/30/2020
574"The results from this study are promising to people around the world who Moonray-7/17/2020
573The key takeaway It is worth noting that Eli Lilly's lineup goes beyond Moonray-7/8/2020
572All Time High on LLY today at $168.92. o~~~ OMoonray-7/6/2020
571LLY today, up with the DOW, 162.86 +5.83 (3.71%) Point & Figure chart says tMoonray-6/25/2020
570Lilly's Covid-19 drug could be ready for use as soon as Sept, says chief scMoonray-6/23/2020
569Point & Figure has a new bullish objective ($219) with buy point $148-$152. Moonray-6/19/2020
568LLY should be bought at the two EMA and gap at $150: [graphic] o~~~ OMoonray-6/19/2020
567Recap of the Week’s Most Important Stories: Lilly Begins Phase III Study on OluMoonray-6/19/2020
566Lilly commences Phase III trial of baricitinib to treat Covid-19 Eli Lilly has Moonray-6/18/2020
565Eli Lilly Up Over 12%, On Pace for Largest Percent Increase Since October 2008 Moonray16/16/2020
564FDA Approves Lilly's New Rapid-acting Insulin Lyumjev FDA approves Lyumjev™Moonray-6/16/2020
563Eli Lilly Shares Surge After Successful 'Verzenio' Breast Cancer Drug TMoonray16/16/2020
562Eli Lilly Is a Big Pharma Play With Big Potential o~~~ OMoonray-6/15/2020
561Covid Report: Eli Lilly Says Its Arthritis Drug Could Tackle Coronavirus PharmMoonray-6/15/2020
560I Like Eli Lilly, But I Like It Better At The $130 Level Rick Pendergraft - Jun.Moonray16/11/2020
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News